Key Record Dates
ClinicalTrials.gov Identifier: | NCT02402660 |
---|---|
Brief Title: | Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE) |
First Submitted : | March 9, 2015 |
First Submitted that Met QC Criteria : | March 27, 2015 |
First Posted : | March 30, 2015 (Estimate) |
Last Update Submitted that Met QC Criteria : | May 1, 2020 |
Last Update Posted : | May 5, 2020 |